Evolution in Massive and Submassive Pulmonary Embolism Treatment: PERT

CLICK HERE FOR COMPLIMENTARY PRE-REGISTRATION >>

SUBMIT TO CASE COMPETITION >> 

All times are in Eastern Time

Topics

• Illustrate the importance of PERT program and its implications on clinical outcomes
• Discuss the components of a system wide PERT program and how it can be functional
• Identify best patients for anticoagulation alone, pharmacomechanical lysis, endovascular embolectomy, or systemic lysis
• List steps for catheter directed pharmacomechanical lysis, including facilitated lysis
• Technical aspect of endovascular thrombectomy

Moderators

• Subhash Banerjee, MD, University of Texas Southwestern Medical Center
• Mehdi Shishehbor, DO, MPH, PhD, University Hospitals of Cleveland

Faculty

• Christopher Huff, MD, Ohio Health
• Jay Giri, MD, University of Pennsylvania
• Jun Li, MD, University Hospitals

This activity has been approved for AMA PRA Category 1 Credit™. Educational Grants provided by: Boston Scientific Corporation and Inari Medical ·